Australian Clinical Labs Health Care

$3.44 0.04 (1.18%)

High $3.45	Low $3.39	Trades 1,017	Turnover $1,031,103	Volume 301,613
30 June 2023 at 4:10pm

Register to track ACL and receive email alerts.

Market Cap (16-May) $614,874,944 (281st)	Close (30-Jun) $3.44 0 (0%)	Volume (30-Jun) 301,613	Shortsold (5-May) 5,242,611 (2.64%) (96th)
52w High $3.81	52w Low $2.06	P/E 14.73	EPS 0.15

	Subject
	ACL ACL Ann: 1H FY22 Updated Profit Guidance
	1 (current) 2 3
	ACL ACL Ann: Notice of Annual General Meeting/Proxy Form
	ACL ACL Ann: Appendix 4G
	ACL ACL Ann: Annual Report to shareholders
	ACL ACL Ann: FY21 financial results investor presentation
	ACL ACL Ann: Full Year Statutory Accounts
	ACL ACL Ann: Preliminary Final Report
	ACL ACL Ann: FY21 financial results investor webinar details
	ACL ACL Ann: FY21 financial results release date and 2021 AGM details
	ACL ACL Ann: Notification regarding unquoted securities - ACL
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Upgraded FY21 earnings guidance by 10 to 15%
	ACL ACL Ann: Appendix 3G
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Confirmation of dispatch of holding statements
	ACL ACL Ann: Amended notice - ceasing to be a substantial shareholder
	ACL ACL Ann: Top 20 Shareholders and Investor ranges reports
	ACL ACL Ann: ASX market release - satisfaction of conditions
	ACL ACL Ann: Ceasing to be a substantial holder
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Satisfaction of conditions for conditional market
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Initial Director's Interest Notice
	ACL ACL Ann: Initial Director's Interest Notice
	ACL ACL Ann: Initial Director's Interest Notice
	ACL ACL Ann: Initial Director's Interest Notice
	ACL ACL Ann: Initial Director's Interest Notice
	ACL ACL Ann: Initial Director's Interest Notice
	ACL ACL Ann: Initial Director's Interest Notice
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Pre-quotation disclosure
	ACL ACL Ann: Indicative top 20 holders
	ACL ACL Ann: Indicative distribution schedule
	ACL ACL Ann: Securities trading policy
	ACL ACL Ann: Corporate governance statement
	ACL ACL Ann: Rights plan rules
	ACL ACL Ann: SunDoctors 27 December 2020 financial statements
	ACL ACL Ann: SunDoctors 28 June 2020 financial statements
	ACL ACL Ann: SunDoctors 30 June 2019 financial statements
	ACL ACL Ann: SunDoctors 24 June 2018 financial statements
	ACL ACL Ann: ACL 31 December 2020 financial statements
	ACL ACL Ann: Clinical Laboratories 30 June 2020 financial statements
	ACL ACL Ann: Clinical Laboratories 30 June 2019 financial statements
	ACL ACL Ann: Clinical Laboratories 30 June 2018 financial statements
	ACL ACL Ann: Constitution
	ACL ACL Ann: Appendix 1A and information form and checklist
	ACL ACL Ann: Admission to Official List

Register to track ACL and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
15-May	$3.05	925,652	+0.01 (0.33%)
14-May	$3.04	657,745	+0.02 (0.66%)
12-May	$3.02	1,467,502	-0.17 (5.33%)
08-May	$3.19	490,580	0.00 (0.00%)
07-May	$3.19	1,204,931	+0.09 (2.90%)
05-May	$3.10	678,106	-0.04 (1.27%)
02-May	$3.14	538,356	+0.01 (0.32%)
01-May	$3.13	532,369	+0.01 (0.32%)
30-Apr	$3.12	653,289	+0.09 (2.97%)
28-Apr	$3.03	997,120	+0.02 (0.66%)
24-Apr	$3.01	759,629	+0.01 (0.33%)
17-Apr	$3.00	2,049,343	0.00 (0.00%)
16-Apr	$3.00	739,215	+0.05 (1.69%)
14-Apr	$2.95	306,562	-0.02 (0.67%)
11-Apr	$2.97	313,361	-0.09 (2.94%)
9 up, 4 down, and 2 flat days